[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:pancreatic-ductal-adenocarcinoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":314,"states":348},"Pancreatic Ductal Adenocarcinoma",149,128,[8,16,23,29,35,42,48,55,61,67,73,79,86,92,98,104,111,117,123,129,135,141,147,153,159,165,171,177,183,189,194,200,206,212,218,224,230,236,242,248,254,260,266,272,278,284,290,296,302,308],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06937177","Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy",[12],"Phase 2","RECRUITING","2026-08-26T02:17:10.213717Z","2026-07-19T19:36:05.060327Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06904378","ONT01 and Gemcitabine\u002FNab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma",[20],"Phase 1\u002FPhase 2","2026-08-26T02:15:58.452248Z","2026-07-05T05:32:16.702532Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT07199764","Maintenance Combinatorial Myeloid Immunotherapy for Unresectable Pancreatic Cancer",[12],"2026-08-26T02:16:35.654046Z","2026-07-05T05:32:16.659384Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT07450859","A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)",[12],"2026-08-26T02:16:54.044282Z","2026-05-05T02:43:29.676369Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":40,"content_modified":41},"NCT05723107","EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)",[39],"Phase 1","2026-08-26T02:19:03.581490Z","2026-05-05T02:43:29.525128Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT06821997","NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial",[12],"2026-08-26T02:18:33.598205Z","2026-05-05T02:43:29.465878Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":53,"content_modified":54},"NCT04005690","Targeted Pathway Inhibition in Patients With Pancreatic Cancer",[52],"Early Phase 1","2026-08-26T02:17:43.321968Z","2026-05-05T02:43:29.394078Z",{"nct_id":56,"title":57,"phases":58,"status":13,"updated_at":59,"content_modified":60},"NCT07283705","A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer",[12],"2026-08-26T02:17:00.709807Z","2026-05-05T02:43:29.390394Z",{"nct_id":62,"title":63,"phases":64,"status":13,"updated_at":65,"content_modified":66},"NCT06984562","Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer",[],"2026-08-26T02:17:50.500039Z","2026-05-05T02:43:29.370573Z",{"nct_id":68,"title":69,"phases":70,"status":13,"updated_at":71,"content_modified":72},"NCT06843551","The Miami \"EMPIRE\" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation",[12],"2026-08-26T02:16:54.876240Z","2026-05-05T02:43:29.351192Z",{"nct_id":74,"title":75,"phases":76,"status":13,"updated_at":77,"content_modified":78},"NCT06454383","Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer",[39],"2026-08-26T02:16:11.347936Z","2026-05-05T02:43:29.350803Z",{"nct_id":80,"title":81,"phases":82,"status":13,"updated_at":84,"content_modified":85},"NCT07252232","Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)",[83],"Phase 3","2026-08-26T02:16:23.080181Z","2026-05-05T02:43:29.336625Z",{"nct_id":87,"title":88,"phases":89,"status":13,"updated_at":90,"content_modified":91},"NCT07030283","Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis",[39],"2026-08-26T02:18:07.037408Z","2026-05-05T02:43:29.285390Z",{"nct_id":93,"title":94,"phases":95,"status":13,"updated_at":96,"content_modified":97},"NCT04990609","EUS-RFA PANCARDINAL-1 Trial",[12],"2026-08-26T02:15:01.639696Z","2026-05-05T02:43:29.052625Z",{"nct_id":99,"title":100,"phases":101,"status":13,"updated_at":102,"content_modified":103},"NCT06158139","Autologous CAR-T Cells Targeting B7-H3 in PDAC",[39],"2026-08-26T02:15:17.167444Z","2026-05-05T02:43:28.657528Z",{"nct_id":105,"title":106,"phases":107,"status":13,"updated_at":109,"content_modified":110},"NCT05254171","Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer",[108],"Phase 2\u002FPhase 3","2026-08-26T02:16:29.226604Z","2026-05-05T02:43:28.642468Z",{"nct_id":112,"title":113,"phases":114,"status":13,"updated_at":115,"content_modified":116},"NCT06079346","A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic Cancer",[108],"2026-08-26T02:17:12.307088Z","2026-05-05T02:43:28.619174Z",{"nct_id":118,"title":119,"phases":120,"status":13,"updated_at":121,"content_modified":122},"NCT06790602","Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma",[12],"2026-08-26T02:18:00.873391Z","2026-05-05T02:43:28.529478Z",{"nct_id":124,"title":125,"phases":126,"status":13,"updated_at":127,"content_modified":128},"NCT06673017","PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)",[39],"2026-08-26T02:18:57.189473Z","2026-05-05T02:43:28.500784Z",{"nct_id":130,"title":131,"phases":132,"status":13,"updated_at":133,"content_modified":134},"NCT06648434","MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma",[39],"2026-08-26T02:18:44.395098Z","2026-05-05T02:43:28.495750Z",{"nct_id":136,"title":137,"phases":138,"status":13,"updated_at":139,"content_modified":140},"NCT05851924","A Study of NALIRIFOX in Combination With Radiation Therapy in People With Pancreatic Ductal Adenocarcinoma (PDAC)",[12],"2026-08-26T02:18:09.641312Z","2026-05-05T02:43:28.335506Z",{"nct_id":142,"title":143,"phases":144,"status":13,"updated_at":145,"content_modified":146},"NCT06831136","Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma",[12],"2026-08-26T02:19:00.742020Z","2026-05-05T02:43:27.957417Z",{"nct_id":148,"title":149,"phases":150,"status":13,"updated_at":151,"content_modified":152},"NCT06423326","Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer",[12],"2026-08-26T02:15:50.539717Z","2026-05-05T02:43:27.860838Z",{"nct_id":154,"title":155,"phases":156,"status":13,"updated_at":157,"content_modified":158},"NCT06922591","Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients",[20],"2026-08-26T02:18:56.409949Z","2026-05-05T02:43:27.806278Z",{"nct_id":160,"title":161,"phases":162,"status":13,"updated_at":163,"content_modified":164},"NCT07096362","Utility of ctDNA in Early Switch of First-line mFOLFIRINOX in Metastatic Pancreatic Ductal Adenocarcinoma",[12],"2026-08-26T02:18:47.742071Z","2026-05-05T02:43:27.622110Z",{"nct_id":166,"title":167,"phases":168,"status":13,"updated_at":169,"content_modified":170},"NCT07089940","OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma",[52],"2026-08-26T02:18:36.226508Z","2026-05-05T02:43:27.505572Z",{"nct_id":172,"title":173,"phases":174,"status":13,"updated_at":175,"content_modified":176},"NCT07522073","A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma",[83],"2026-08-26T02:17:19.710918Z","2026-05-05T02:43:27.421423Z",{"nct_id":178,"title":179,"phases":180,"status":13,"updated_at":181,"content_modified":182},"NCT07024615","A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer",[39],"2026-08-26T02:15:26.669629Z","2026-05-05T02:43:27.401522Z",{"nct_id":184,"title":185,"phases":186,"status":13,"updated_at":187,"content_modified":188},"NCT06593431","Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial",[83],"2026-08-26T02:19:29.922117Z","2026-05-05T02:43:27.336520Z",{"nct_id":190,"title":191,"phases":192,"status":13,"updated_at":157,"content_modified":193},"NCT07049055","A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer",[20],"2026-05-05T02:43:27.292040Z",{"nct_id":195,"title":196,"phases":197,"status":13,"updated_at":198,"content_modified":199},"NCT05132504","Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer",[12],"2026-08-26T02:16:13.426928Z","2026-05-05T02:43:27.286666Z",{"nct_id":201,"title":202,"phases":203,"status":13,"updated_at":204,"content_modified":205},"NCT06048484","Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma",[12],"2026-08-26T02:18:37.277498Z","2026-05-05T02:43:27.257274Z",{"nct_id":207,"title":208,"phases":209,"status":13,"updated_at":210,"content_modified":211},"NCT06941857","NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer",[12],"2026-08-26T02:16:40.941792Z","2026-05-05T02:43:27.133343Z",{"nct_id":213,"title":214,"phases":215,"status":13,"updated_at":216,"content_modified":217},"NCT07214298","Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma",[20],"2026-08-26T02:18:14.396999Z","2026-05-05T02:43:27.106061Z",{"nct_id":219,"title":220,"phases":221,"status":13,"updated_at":222,"content_modified":223},"NCT06958328","Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer",[83],"2026-08-26T02:17:53.433613Z","2026-05-05T02:43:26.956155Z",{"nct_id":225,"title":226,"phases":227,"status":13,"updated_at":228,"content_modified":229},"NCT06182072","ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC)",[39],"2026-08-26T02:18:15.214990Z","2026-05-05T02:43:26.926645Z",{"nct_id":231,"title":232,"phases":233,"status":13,"updated_at":234,"content_modified":235},"NCT03608631","iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation",[20],"2026-08-26T02:18:27.904411Z","2026-05-05T02:43:26.686443Z",{"nct_id":237,"title":238,"phases":239,"status":13,"updated_at":240,"content_modified":241},"NCT05968326","A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC",[12],"2026-08-26T02:15:27.567165Z","2026-05-05T02:35:31.709824Z",{"nct_id":243,"title":244,"phases":245,"status":13,"updated_at":246,"content_modified":247},"NCT06639724","Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer",[39],"2026-08-26T02:17:57.117858Z","2026-05-05T02:35:31.640919Z",{"nct_id":249,"title":250,"phases":251,"status":13,"updated_at":252,"content_modified":253},"NCT07409272","A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer",[83],"2026-08-26T02:15:25.633039Z","2026-04-29T02:57:57.145671Z",{"nct_id":255,"title":256,"phases":257,"status":13,"updated_at":258,"content_modified":259},"NCT03977233","Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer",[12],"2026-08-26T02:17:36.611194Z","2026-04-29T02:57:57.103225Z",{"nct_id":261,"title":262,"phases":263,"status":13,"updated_at":264,"content_modified":265},"NCT05482893","Spevatamig (PT886) as Monotherapy or in Combination With Chemo and\u002For ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)",[20],"2026-08-26T02:16:36.513735Z","2026-07-19T19:36:05.117317Z",{"nct_id":267,"title":268,"phases":269,"status":13,"updated_at":270,"content_modified":271},"NCT05382559","A Study of ASP3082 in Adults With Advanced Solid Tumors",[39],"2026-08-26T02:16:46.951087Z","2026-07-05T05:32:16.801787Z",{"nct_id":273,"title":274,"phases":275,"status":13,"updated_at":276,"content_modified":277},"NCT06598007","A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors",[20],"2026-08-26T02:17:24.721169Z","2026-07-05T05:32:16.762638Z",{"nct_id":279,"title":280,"phases":281,"status":13,"updated_at":282,"content_modified":283},"NCT06428409","A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)",[20],"2026-08-26T02:17:22.949982Z","2026-07-05T05:32:16.751250Z",{"nct_id":285,"title":286,"phases":287,"status":13,"updated_at":288,"content_modified":289},"NCT06917079","BBO-11818 in Adult Subjects With KRAS Mutant Cancer",[39],"2026-08-26T02:18:35.425468Z","2026-07-05T05:32:16.701709Z",{"nct_id":291,"title":292,"phases":293,"status":13,"updated_at":294,"content_modified":295},"NCT06983743","A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors",[39],"2026-08-26T02:18:21.216897Z","2026-07-05T03:45:20.456891Z",{"nct_id":297,"title":298,"phases":299,"status":13,"updated_at":300,"content_modified":301},"NCT07629960","A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations",[20],"2026-08-26T02:15:38.131683Z","2026-06-06T00:48:49.532877Z",{"nct_id":303,"title":304,"phases":305,"status":13,"updated_at":306,"content_modified":307},"NCT05431270","Dose Escalation\u002FExpansion Study of Mavrostobart (PT199), an Anti-CD73 MAb, Administered Alone and in Combination with a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)",[20],"2026-08-26T02:16:21.385056Z","2026-05-05T02:43:29.392794Z",{"nct_id":309,"title":310,"phases":311,"status":13,"updated_at":312,"content_modified":313},"NCT06835569","A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations",[39],"2026-08-26T02:18:58.141497Z","2026-05-05T02:43:29.166414Z",[315,319,323,327,330,333,336,339,342,345],{"biomarker":316,"count":317,"slug":318},"GTPase KRas",27,"gtpase-kras",{"biomarker":320,"count":321,"slug":322},"Claudin-18 Isoform A2",4,"claudin-18-isoform-a2",{"biomarker":324,"count":325,"slug":326},"ATM Gene",3,"atm-gene",{"biomarker":328,"count":325,"slug":329},"BRCA1 Gene","brca1-gene",{"biomarker":331,"count":325,"slug":332},"BRCA2 Gene","brca2-gene",{"biomarker":334,"count":325,"slug":335},"MSI1 Gene","msi1-gene",{"biomarker":337,"count":325,"slug":338},"MTAP Gene","mtap-gene",{"biomarker":340,"count":325,"slug":341},"Partner and Localizer of BRCA2","partner-and-localizer-of-brca2",{"biomarker":343,"count":325,"slug":344},"Programmed Cell Death 1 Ligand 1","programmed-cell-death-1-ligand-1",{"biomarker":346,"count":325,"slug":347},"RAS Family Oncogene","ras-family-oncogene",[349,353,357,361,365,369,373,377,381,385,389,392,396,399,403,407,411,414,418,421,424,428,432,436],{"state":350,"count":351,"slug":352},"Texas",79,"texas",{"state":354,"count":355,"slug":356},"California",64,"california",{"state":358,"count":359,"slug":360},"New York",59,"new-york",{"state":362,"count":363,"slug":364},"Florida",46,"florida",{"state":366,"count":367,"slug":368},"Virginia",40,"virginia",{"state":370,"count":371,"slug":372},"Massachusetts",38,"massachusetts",{"state":374,"count":375,"slug":376},"Tennessee",35,"tennessee",{"state":378,"count":379,"slug":380},"Michigan",33,"michigan",{"state":382,"count":383,"slug":384},"Pennsylvania",30,"pennsylvania",{"state":386,"count":387,"slug":388},"Ohio",29,"ohio",{"state":390,"count":317,"slug":391},"North Carolina","north-carolina",{"state":393,"count":394,"slug":395},"Colorado",23,"colorado",{"state":397,"count":394,"slug":398},"Missouri","missouri",{"state":400,"count":401,"slug":402},"Minnesota",22,"minnesota",{"state":404,"count":405,"slug":406},"Connecticut",21,"connecticut",{"state":408,"count":409,"slug":410},"New Jersey",20,"new-jersey",{"state":412,"count":409,"slug":413},"Utah","utah",{"state":415,"count":416,"slug":417},"Maryland",19,"maryland",{"state":419,"count":416,"slug":420},"Washington","washington",{"state":422,"count":416,"slug":423},"Wisconsin","wisconsin",{"state":425,"count":426,"slug":427},"Arizona",18,"arizona",{"state":429,"count":430,"slug":431},"Georgia",16,"georgia",{"state":433,"count":434,"slug":435},"Illinois",15,"illinois",{"state":437,"count":438,"slug":439},"Indiana",14,"indiana"]